Hiroharu Yamashita Selected Research

Hiroharu Yamashita Research Topics

Disease

58	Stomach Neoplasms (Stomach Cancer) 12/2022 - 11/2004
45	Neoplasms (Cancer) 01/2022 - 11/2004
23	Neoplasm Metastasis (Metastasis) 12/2022 - 10/2005
13	Carcinoma (Carcinomatosis) 01/2021 - 11/2005
9	Ascites 01/2017 - 01/2010
7	Lymphatic Metastasis 07/2022 - 10/2005
6	Sarcopenia 05/2022 - 01/2020
5	Esophageal Squamous Cell Carcinoma 07/2022 - 10/2016
5	Esophageal Neoplasms (Esophageal Cancer) 09/2021 - 01/2016
5	Adenocarcinoma 03/2021 - 10/2005
3	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 09/2005
2	Obesity 04/2021 - 06/2020
2	Pneumonia (Pneumonitis) 03/2021 - 10/2016
2	Flatulence 02/2021 - 08/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 09/2014
2	Wounds and Injuries (Trauma) 08/2018 - 01/2010
2	Vomiting 01/2018 - 01/2010
2	Colonic Neoplasms (Colon Cancer) 05/2006 - 09/2005
1	Abdominal Abscess 06/2022
1	Pneumothorax 06/2022
1	Duodenal Neoplasms (Duodenal Cancer) 01/2022
1	Esophageal Fistula 07/2021
1	Residual Neoplasm 07/2021
1	Pancreatic Fistula (Pancreatic Fistulas) 03/2021
1	Neuroendocrine Carcinoma 02/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2021
1	Avitaminosis (Vitamin Deficiency) 11/2018
1	Infections 01/2018

Drug/Important Bio-Agent (IBA)

13	Paclitaxel (Taxol)FDA LinkGeneric 11/2021 - 12/2008
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2006
7	lysophosphatidic acidIBA 01/2017 - 12/2004
5	Indicators and Reagents (Reagents)IBA 02/2022 - 03/2007
5	ErbB Receptors (EGF Receptor)IBA 09/2008 - 11/2004
4	Biological ProductsIBA 01/2022 - 01/2006
4	Coloring Agents (Dyes)IBA 10/2020 - 06/2007
3	C-Reactive ProteinIBA 02/2021 - 10/2005
3	Hyaluronic Acid (Hyaluronan)IBA 01/2014 - 06/2007
3	Fibrinogen (Factor I)FDA Link 06/2009 - 10/2005
2	AntigensIBA 01/2022 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
2	RNA (Ribonucleic Acid)IBA 05/2021 - 01/2020
2	B7-H1 AntigenIBA 02/2021 - 01/2021
2	Programmed Cell Death 1 ReceptorIBA 02/2021 - 01/2017
2	Gemcitabine FDA Link 01/2021 - 09/2014
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2020 - 12/2015
2	Phospholipases A1 (Phospholipase A1)IBA 01/2017 - 03/2015
2	LysophospholipidsIBA 01/2017 - 02/2005
2	PhosphatidylserinesIBA 01/2017 - 03/2015
2	RacivirIBA 01/2014 - 08/2013
2	Indigo Carmine (Indigo Blue)IBA 01/2014 - 06/2009
2	Aligeron (AS 2)IBA 01/2010 - 01/2009
2	Peptide Hormones (Polypeptide Hormones)IBA 09/2008 - 07/2007
2	Phosphotransferases (Kinase)IBA 09/2008 - 09/2005
2	Lysophosphatidic Acid ReceptorsIBA 01/2006 - 12/2004
2	LigandsIBA 02/2005 - 11/2004
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 02/2005 - 11/2004
1	taxaneIBA 12/2022
1	PlatinumIBA 12/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	CarbohydratesIBA 01/2022
1	NivolumabIBA 11/2021
1	CytokinesIBA 03/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021
1	130-nm albumin-bound paclitaxelIBA 01/2021
1	Carmine (Natural Red 4)IBA 10/2020
1	4-azidosalicylic acid-phosphatidylserineIBA 09/2020
1	pembrolizumabIBA 01/2020
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	Immune Checkpoint ProteinsIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Deoxyribonuclease I (Nickase)IBA 12/2018
1	IronIBA 11/2018
1	Analgesics (Analgesic Drugs)IBA 08/2018

Therapy/Procedure

22	Gastrectomy 05/2022 - 11/2005
20	Drug Therapy (Chemotherapy) 12/2022 - 07/2009
12	Esophagectomy 07/2022 - 08/2011
10	Therapeutics 12/2022 - 04/2014
10	Lymph Node Excision (Lymph Node Dissection) 07/2021 - 01/2010
5	Adjuvant Chemotherapy 12/2022 - 06/2009
4	Combination Drug Therapy (Combination Chemotherapy) 03/2017 - 05/2012
3	Operative Surgical Procedures 01/2022 - 01/2016
2	Appendectomy 06/2022 - 01/2010
2	Neoadjuvant Therapy 02/2022 - 09/2019
2	Pancreaticoduodenectomy 01/2022 - 03/2021
2	Radiotherapy 07/2021 - 08/2017
2	Chemoradiotherapy 07/2021 - 04/2020
2	Length of Stay 03/2021 - 12/2017
2	Laparotomy 12/2018 - 01/2014
2	Catheters 01/2014 - 08/2013
1	Cholecystectomy 06/2022
1	Transjugular Intrahepatic Portasystemic Shunt 06/2022
1	Photochemotherapy (Photodynamic Therapy) 07/2021
1	Salvage Therapy 07/2021
1	Contraindications 07/2021
1	Metastasectomy 07/2021
1	Renal Dialysis (Hemodialysis) 01/2021
1	Splenectomy 09/2019
1	Immunotherapy 04/2018